Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study
@article{TCR80017,
author = {Luchun Li and Ting Wang and Zhijuan Wu and Yan Li and Huiwen Ma and Lulu Wang and Shuangyi Lei and Wen Chen},
title = {Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study},
journal = {Translational Cancer Research},
volume = {12},
number = {11},
year = {2023},
keywords = {},
abstract = {},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/80017}
}